HHS & DEA Extend Telemedicine Flexibilities For Prescribing Controlled Medications Through 2026

The Department of Health and Human Services (HHS) and the Drug Enforcement Administration (DEA) announced a fourth temporary extension of telemedicine flexibilities, enabling the receipt of prescriptions for controlled medications without a prior in-person visit. The extension runs from January 1, 2026, through December 31, 2026, preventing disruptions in care while permanent rules are finalized.

“Under these telemedicine flexibilities, DEA-registered practitioners are permitted to remotely prescribe Schedule II-V controlled medications via audio-video telemedicine encounters, including Schedule III-V narcotic controlled medications approved by the Food and Drug Administration (FDA) for maintenance and withdrawal management treatment of . . .